Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. With global and U.S. headquarters in Parsippany, New Jersey, USA, and international headquarters in Zug, Switzerland, Actavis is the world’s 3rd largest generics prescription drug manufacturer. Operating as Actavis Pharma, the Company develops, manufactures, and markets generic, branded generic, legacy brands and Over-the-Counter products in over 60 countries. Actavis Specialty Brands is the Company’s global branded specialty pharmaceutical business, which develops and markets a portfolio of approximately 40 products principally in the U.S. and Canada. In addition, Actavis is the 4th largest U.S. generic pharmaceutical product distributor through its Anda, Inc. business, and also develops and out-licenses generic pharmaceutical products outside of the U.S. through its Medis third-party business.